4DMEDICAL Ltd (4DX) - Total Assets
Based on the latest financial reports, 4DMEDICAL Ltd (4DX) holds total assets worth AU$139.55 Million AUD (≈ $98.74 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 4DX total equity for net asset value and shareholders' equity analysis.
4DMEDICAL Ltd - Total Assets Trend (2014–2025)
This chart illustrates how 4DMEDICAL Ltd's total assets have evolved over time, based on quarterly financial data.
4DMEDICAL Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
4DMEDICAL Ltd's total assets of AU$139.55 Million consist of 18.0% current assets and 82.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 7.3% |
| Accounts Receivable | AU$1.41 Million | 1.5% |
| Inventory | AU$919.63K | 1.0% |
| Property, Plant & Equipment | AU$7.47 Million | 7.9% |
| Intangible Assets | AU$23.86 Million | 25.2% |
| Goodwill | AU$42.71 Million | 45.1% |
Asset Composition Trend (2014–2025)
This chart illustrates how 4DMEDICAL Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 4DMEDICAL Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 4DMEDICAL Ltd's current assets represent 18.0% of total assets in 2025, a decrease from 39.8% in 2014.
- Cash Position: Cash and equivalents constituted 7.3% of total assets in 2025, down from 24.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 70.0% of total assets, an increase from 10.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 45.1% of total assets.
4DMEDICAL Ltd Competitors by Total Assets
Key competitors of 4DMEDICAL Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.54 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.72 Billion |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
|
China | CN¥1.42 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$15.57 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
4DMEDICAL Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.57 | 1.03 | 14.80 |
| Quick Ratio | 6.48 | 0.98 | 14.75 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$53.90 Million | AU$631.45K | AU$42.99 Million |
4DMEDICAL Ltd - Advanced Valuation Insights
This section examines the relationship between 4DMEDICAL Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 37.59 |
| Latest Market Cap to Assets Ratio | 17.51 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | AU$94.81 Million |
| Market Capitalization | $1.66 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values 4DMEDICAL Ltd's assets at a significant premium (17.51x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: 4DMEDICAL Ltd's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for 4DMEDICAL Ltd (2014–2025)
The table below shows the annual total assets of 4DMEDICAL Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$94.81 Million ≈ $67.09 Million |
0.00% |
| 2024-12-31 | AU$94.81 Million ≈ $67.09 Million |
-21.00% |
| 2024-06-30 | AU$120.02 Million ≈ $84.92 Million |
0.00% |
| 2023-12-31 | AU$120.02 Million ≈ $84.92 Million |
+29.16% |
| 2023-06-30 | AU$92.92 Million ≈ $65.75 Million |
0.00% |
| 2022-12-31 | AU$92.92 Million ≈ $65.75 Million |
+25.04% |
| 2022-06-30 | AU$74.31 Million ≈ $52.58 Million |
0.00% |
| 2021-12-31 | AU$74.31 Million ≈ $52.58 Million |
-19.78% |
| 2021-06-30 | AU$92.64 Million ≈ $65.55 Million |
0.00% |
| 2020-12-31 | AU$92.64 Million ≈ $65.55 Million |
+485.40% |
| 2020-06-30 | AU$15.82 Million ≈ $11.20 Million |
0.00% |
| 2019-12-31 | AU$15.82 Million ≈ $11.20 Million |
+75.36% |
| 2019-06-30 | AU$9.02 Million ≈ $6.39 Million |
0.00% |
| 2018-12-31 | AU$9.02 Million ≈ $6.39 Million |
+65.51% |
| 2018-06-30 | AU$5.45 Million ≈ $3.86 Million |
0.00% |
| 2017-12-31 | AU$5.45 Million ≈ $3.86 Million |
+10.24% |
| 2017-06-30 | AU$4.95 Million ≈ $3.50 Million |
0.00% |
| 2016-12-31 | AU$4.95 Million ≈ $3.50 Million |
+352.80% |
| 2016-06-30 | AU$1.09 Million ≈ $772.87K |
0.00% |
| 2015-12-31 | AU$1.09 Million ≈ $772.87K |
+61.67% |
| 2015-06-30 | AU$675.64K ≈ $478.06K |
0.00% |
| 2014-12-31 | AU$675.64K ≈ $478.06K |
-- |
About 4DMEDICAL Ltd
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more